The final day of the AACR Annual Meeting 2025 will feature two Plenary Sessions, including the morning Plenary Session on Opportunities in Predictive Oncology and a closing Plenary Session to showcase the meeting’s key highlights across the continuum of cancer research.
Adding pembrolizumab before and after surgery to standard of care improved outcomes in previously untreated head and neck cancer patients.
$130,000 over two years to support a postdoctoral or clinical research fellow in conducting ALK-positive lung cancer research.
Muhammad Shaalan Beg, MD, MBA, explained on Monday how clinical investigators can use new technologies to decentralize clinical trials, conducting portions of the trial at…
Takeaways from day 4 of the AACR Annual Meeting 2025 include declining breast cancer mortality, using liquid and tissue biopsy, and more.
AACR’s CancerCareers.org aims to offer unparalleled career services and opportunities to cancer biomedical researchers looking to advance in their scientific career, and to potential employers…
Ravindra Uppaluri, MD, PhD, presented results on Sunday that could soon prove practice-changing in patients with head and neck squamous cell carcinoma.
Catherine J. Wu, MD, FAACR, highlighted the promise of personalized neoantigen cancer vaccines—one of four exciting and emerging areas of science examined during the session…
Overview for AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning
ALL PRODUCT PURCHASES ARE 100% TAX DEDUCTIBLE CHARITABLE DONATIONS AND GO DIRECTLY TO LIVESAVING CANCER RESEARCH. FREE SHIPPING AVAILABLE FOR ORDERS OF $75 AND UP.…
Five thought leaders in immunotherapy, breast cancer, precision medicine, and lung cancer modeling will present during unique sessions Tuesday evening.
